New brain scans aim to catch Huntington's cognitive decline early
NCT ID NCT07503743
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to create more sensitive cognitive tests for Huntington's disease by combining brain imaging (PET and MRI) with blood markers. Researchers will study 90 participants—healthy controls, pre-symptomatic gene carriers, and early-stage patients—to understand how brain changes relate to thinking skills. The goal is to detect subtle cognitive problems earlier and better classify different types of cognitive decline, which could help future treatment trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUNTINGTON'S DISEASE (HD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital de la Sant aCreu i Sant Pau
Barcelona, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.